News Center
With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.
14
2025
-
04
Honored and Awarded! The 2025 Wuzhen Health Conference concludes, with Linyi Pharmaceutical winning multiple West Lake Awards!
Classification：
行业新闻
Corporate News
4 On December 12, 2025, the 2025 Wuzhen Health Conference and the 4th OTC Conference concluded successfully. As a highly influential annual event in China's pharmaceutical and healthcare industry, this year's conference attracted pharmaceutical companies, experts, scholars, and industry leaders from all over the world. Koyuan Pharmaceutical (Stock Code: 301281.SZ) & Liny Pharmaceutical shone brightly at this conference, winning numerous prestigious awards and returning home with great success, once again demonstrating the company's outstanding strength.
During the conference, Koyuan Pharmaceutical & Liny Pharmaceutical made a stunning appearance with a booth showcasing digital and intelligent technologies, attracting numerous attendees to stop and interact. With its outstanding corporate strength and product performance, the company not only received unanimous praise from new and old customers but also won numerous awards at the conference.
Liny Pharmaceutical, with its excellent technology-driven strength and strategic layout, became a "2025 Wuzhen Health Conference • VIP Strategic Partner"; Liny Pharmaceutical's leaders, Li Hongfu and Huang Fangsheng, jointly won the "West Lake Award • Pioneer Figures in China's Pharmaceutical Industry"; and Liny Pharmaceutical's new product, "Ambroxol Hydrochloride Drops," won the "West Lake Award • Most Popular Product in Pharmacies".
The four weighty "West Lake Awards" are not only a commendation of the company's current achievements but also the best affirmation of Liny Pharmaceutical's adherence to its pharmaceutical ideals for over 20 years. "Healthy China, Heartfelt Commitment" is engraved on the walls of Liny Pharmaceutical and in the hearts of every Liny employee. In an era that pursues speed and efficiency, Liny Pharmaceutical has chosen a more difficult path—using time to hone quality and using perseverance to earn trust.
During the conference, Chen Yongfang, Vice President of Retail at Liny Pharmaceutical, accepted an exclusive interview with Sina Weibo, sharing Liny Pharmaceutical's successful experience in terms of corporate development, product layout, and future planning. In its more than 20 years of existence, the company has continuously cultivated the chronic disease field, possessing numerous classic products in the areas of blood sugar control, cardiovascular health, and the central nervous system, accumulating extensive R&D and market advantages.
In recent years, the company has continued to expand its product pipeline, investing resources in the research and development and introduction of new products. This year, the company's new product, "Ambroxol Hydrochloride Drops," received authoritative recognition, greatly enhancing the product's market credibility and Liny Pharmaceutical's Brand influence. In the future, the company will continue to launch higher-quality products and health solutions, building a diversified and comprehensive product matrix to meet the health needs of different groups.
Winning awards is not the end but a new beginning. The honor is an affirmation of the past and a spur to the future. Liny Pharmaceutical, returning home with honors, is moving towards a new journey with even more determined steps.
Related news
ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China
